A PRELIMINARY EVALUATION OF ACEPROMAZINE (PLEGICIL)
Abstract
Seventy-six per cent of 50 patients who had been resistant to all other therapies responded favorably to a program based on acepromazine's psychosedative action. We feel that these results were obtained because the regimen emphasized individualization of dosage, use of adjunct medications as indicated, and rehabilitation services to guide the patients through the "door to reality" opened by this new psychopharmacological agent.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).